T3	Effect 43 86	respiratory syncytial virus (RSV) infection
T4	Subject 90 146	a patient with a long-standing history of refractory CLL
T6	Treatment 169 190	fludarabine phosphate
T8	Drug 169 190	fludarabine phosphate
T9	Treat-Disorder 132 146	refractory CLL
